Overview

Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This study is a multinational study to compare enzastaurin versus placebo in the treatment of patients with brain metastases of lung cancer. Approximately 108 patients will be randomly assigned to receive either enzastaurin or placebo after having completed whole brain radiotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company